Despite Vikram Vedha’s average Box Office, Rs 1000 crores rides on Hrithik Roshan with Fighter, War 2 and Krrish 4

Hrithik Roshan might not have been able to recover Vikram Vedha’s losses yet but the actor has as much as Rs. 1000 crores riding on him. He currently has Fighter, War 2 and Krrish 4 in the pipeline. While his last film underperformed at the Box Office, he has some of the most-awaited movies in his kitty.

Vikram Vedha was made on a budget of Rs. 120 crores. The movie, which was the remake of the Tamil film of the same name, could earn only Rs. 135.03 crores at the Box Office.

A report on Pinkvilla claims that Hrithik has around Rs. 1000 crores riding on him. However, despite the massive amount, producers are not afraid of investing in his movies.

“A collective investment of Rs 1000 crore might be huge for most in the industry, but for Hrithik, there are several avenues of recovery due to his proven box-office records. Despite being an investment of Rs 1000 crore plus, every stakeholder is confident of a recovery on their project,” a source was quoted saying.

Fighter is helmed by Pathaan director Siddharth Anand. It is also the movie which brings Deepika Padukone and Hrithik together for the first time. The action film is expected to wrap up in June.

Hrithik has also paired up with Jr. NTR for the first time for the sequel of 2019’s biggest hit, War. He had previously collaborated with Tiger Shroff. This time, with Jr. NTR joining the cast, the film is likely to appeal in South India too. The movie is helmed by Brahmastra’s Ayan Mukerji and is likely to go on floors in November.

Meanwhile, the much-awaited Krrish 4 might finally go on floors, now that COVID-19 wave has lifted off. Hrithik is expected to begin work on his superhero film towards the end of 2024. The superhero is extremely popular and loved in India. Thus, there is a higher chance that the film might work at the Box Office.

Collectively, Hrithik’s three movies are expected to earn around Rs. 1500 crores at the Box Office. Thus, shareholders are not too worried to invest in the actor at this point of time.